Proscia Stock
Proscia is a health technology company pioneering digital and computational pathology solutions to transform cancer diagnosis and research. The company’s platform leverages AI and advanced software to help pathologists and laboratories digitize workflows, improve diagnostic accuracy, and accelerate breakthroughs in disease understanding and treatment.
Founded: 2014
For more Proscia stock information, or to buy or sell private shares, sign up for a MicroVentures account.
Management Team
| David West Co-Founder and Chief Executive Officer |
| Nathan Buchbinder Co-Founder and Chief Strategy Officer |
| Coleman Stavish Co-Founder and Chief Technology Officer |
